Amphiphilic Tobramycins with Immunomodulatory Properties†
Dr. Goutam Guchhait
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorAnthony Altieri
Department of Internal Medicine and Immunology, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorDr. Balakishan Gorityala
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorXuan Yang
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorDr. Brandon Findlay
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorProf. George G. Zhanel
Department of Medical Microbiology and Medicine, Health Science Centre, Winnipeg, Manitoba, R3T 1R9 (Canada)
Search for more papers by this authorProf. Neeloffer Mookherjee
Department of Internal Medicine and Immunology, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorCorresponding Author
Prof. Frank Schweizer
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)Search for more papers by this authorDr. Goutam Guchhait
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorAnthony Altieri
Department of Internal Medicine and Immunology, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorDr. Balakishan Gorityala
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorXuan Yang
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorDr. Brandon Findlay
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorProf. George G. Zhanel
Department of Medical Microbiology and Medicine, Health Science Centre, Winnipeg, Manitoba, R3T 1R9 (Canada)
Search for more papers by this authorProf. Neeloffer Mookherjee
Department of Internal Medicine and Immunology, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Search for more papers by this authorCorresponding Author
Prof. Frank Schweizer
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)
Department of Chemistry, University of Manitoba, Winnipeg, MB, R3T 2N2 (Canada)Search for more papers by this authorFunding for this project was provided by CIHR (MOP 119335) Research Manitoba and NSERC.
Abstract
Amphiphilic aminoglycosides (AAGs) are an emerging source of antibacterials to combat infections caused by antibiotic-resistant bacteria. Mode-of-action studies indicate that AAGs predominately target bacterial membranes, thereby leading to depolarization and increased permeability. To assess whether AAGs also induce host-directed immunomodulatory responses, we determined the AAG-dependent induction of cytokines in macrophages in the absence or presence of lipopolysaccharide (LPS). Our results show for the first time that AAGs can boost the innate immune response, specifically the recruitment of immune cells such as neutrophils required for the resolution of infections. Moreover, AAGs can selectively control inflammatory responses induced in the presence of endotoxins to prevent septic shock. In conclusion, our study demonstrates that AAGs possess multifunctional properties that combine direct antibacterial activity with host-directed clearance effects reminiscent of those of host-defense peptides.
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Filename | Description |
---|---|
ange_201500598_sm_miscellaneous_information.pdf1.8 MB | miscellaneous_information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1H. W. Boucher, G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, B. Spielberg, J. Bartlett, Clin. Infect. Dis. 2009, 48, 1–12.
- 2M. S. Butler, M. A. Blaskovich, M. A. Cooper, J. Antibiot. 2013, 66, 571–591.
- 3L. Kalan, G. D. Wright, Expert Rev. Mol. Med. 2011, 13, 1-e5/17.
- 4H. Brötz-Oesterhelt, N. A. Brunner, Curr. Opin. Pharmacol. 2008, 8, 564–573.
- 5S. Bera, G. G. Zhanel, F. Schweizer, J. Med. Chem. 2008, 51, 6160–6164.
- 6J. Zhang, F.-I. Chiang, L. Wu, G. P. Czyryca, D. Li, C.-W. J. Chang, Med. Chem. 2008, 51, 7563–7573.
- 7I. Baussanne, A. Bussière, S. Halder, C. Ganem-Elbaz, M. Queberai, M. Riou, J.-M. Paris, E. Ennifar, M.-P. Mingeot-Leclerc, J.-L. Décout, J. Med. Chem. 2010, 53, 119–127.
- 8S. Bera, G. G. Zhanel, F. Schweizer, J. Med. Chem. 2010, 53, 3626–3631.
- 9M. Ouberai, F. El Garch, A. Bussière, M. Riou, D. Alsteens, L. Lins, I. Baussanne, Y. F. Dufrêne, R. Brasseur, J.-L. Décout, M.-P. Mingeot-Leclercq, Biochim. Biophys. Acta Biomembr. 2011, 1808, 1716–1727.
- 10L. Zimmermann, A. Bussiere, M. Ouberai, I. Baussanne, C. Jolivalt, M.-P. Mingeot-Leclercq, J.-L. Decout, J. Med. Chem. 2013, 56, 7691–7705.
- 11G. Sautrey, L. Zimmermann, M. Deleu, A. Delbar, L. S. Machado, K. Jeannot, F. Van Bambeke, J. M. Buyck, J- L. Décout, M.-P. Mingeot-Leclercq, Antimicrob. Agents Chemother. 2014, 58, 4420–4430.
- 12
- 12aI. M. Herzog, K. D. Green, Y. Berkov-Zrihen, M. Feldman, R. R. Vidavski, A. Eldar-Boock, R. Satchi-Fainaro, A. Eldar, S. Garneau-Tsodikova, M. Fridman, Angew. Chem. Int. Ed. 2012, 51, 5652–5656; Angew. Chem. 2012, 124, 5750–5754;
- 12bI. M. Herzog, M. Feldman, A. Eldar-Boock, R. Satchi-Fainaro, M. Fridman, MedChemComm 2013, 4, 120–124.
- 13J. Zhang, K. Keller, J. Y. Takemoto, M. Bensaci, A. Litke, P. G. Czyryca, C-W. T. Chang, J. Antibiot. 2009, 62, 539–544.
- 14V. Udumula, Y. W. Ham, M. Fossa, K. Y. Chan, R. Rai, J. Zhang, J. Li, C-W. T. Chang, Bioorg. Med. Chem. Lett. 2013, 23, 1671–1675.
- 15
- 15aT. Erdos, A. Ullmann, Nature 1959, 183, 618–619;
- 15bM. M. Feldman, D. S. Terry, R. B. Altman, S. C. Blanchard, Nat. Chem. Biol. 2010, 6, 54–62;
- 15cM. Kaul, C. M. Barbieri, D. S. Pilch, J. Am. Chem. Soc. 2006, 128, 1261–1271;
- 15dfor a recent review see: B. Becker, M. A. Cooper, ACS Chem. Biol. 2013, 8, 105–115.
- 16S. C. Mansour, O. M. Pena, R. E. W. Hancock, Trends Immunol. 2014, 35, 443–450.
- 17A. L. Hilchie, K. Wuerth, R. E. W. Hancock, Nat. Chem. Biol. 2013, 9, 761–768.
- 18H. D. Thaker, A. Som, F. Ayaz, D. Lui, W. Pan, R. W. Scott, J. Anguita, G. N. Tew, J. Am. Chem. Soc. 2012, 134, 11088–11091.
- 19O. M. Pena, N. Afacan, J. Pistolic, C. Chen, L. Madera, R. Falsafi, C. D. Fjell, R. E. W. Hancock, PLoSOne 2013, 8, e 52449.
- 20R. Koczulla, G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, K. Issbrücker, P. Unterberger, M. Zaiou, C. Lebherz, A. Karl, P. Raake, A. Pfosser, P. Boekstegers, U. Welsch, P. S. Hiemstra, C. Vogelmeier, R. L. Gallo, M. Clauss, R. Bals, J. Clin. Invest. 2003, 111, 1665–1672.
- 21D. Yang, O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schröder, J. M. Wang, O. M. Howard, J. J. Oppenheim, Science 1999, 286, 525–528.
- 22M. Bothra, R. Lodha, S. K. Kabra, Expert Opin. Pharmacother. 2012, 13, 565–571.
- 23S. Hanessian, M. Tremblay, E. E. Swayze, Tetrahedron 2003, 59, 983–993.
- 24Q. Vicens, E. Westhof, Chem. Biol. 2002, 9, 747–755.
- 25M. Gziut, H. J. MacGregor, T. G. Nevell, T. Mason, D. Laight, J. K. Shute, Br. J. Pharmacol. 2013, 168, 1165–1181.
- 26N. Mookherjee, K. L. Brown, D. M. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, J. P. Powers, J. Bryan, F. S. Brinkman, R. E. W. Hancock, J. Immunol. 2006, 176, 2455–2464.
- 27K. Y. Choi, S. Napper, N. Mookherjee, Immunology 2014, 143, 68–80.
- 28D. M. E. Bowdish, D. J. Davidson, M. G. Scott, R. E. W. Hancock, Antimicrob. Agents Chemother. 2005, 49, 1727–1732.
- 29M. G. Scott, D. J. Davidson, M. R. Gold, D. M. E. Bowdish, R. E. W. Hancock, J. Immunol. 2002, 169, 3883–3891.
- 30S. L. Kunkel, N. W. Lukacs, R. M. Strieter, Ann. N. Y. Acad. Sci. 1994, 730, 134–143.
- 31N. Mukaida, Int. J. Hematol. 2000, 72, 391–398.
- 32
- 32aD. Singh, R. Qi, J. L. Jordan, L. San Mateo, C. C. Kao, J. Biol. Chem. 2013, 288, 8258–8268;
- 32bT. Into, M. Inomata, K. Shibata, Y. Murakami, Cell Immunol. 2010, 264, 104–109.
- 33
- 33aM. G. Scott, E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, J. J. Yu, Y. Li, O. Donini, M. M. Guarna, B. B. Finlay, J. R. North, R. E. W. Hancock, Nat. Biotechnol. 2007, 25, 465–472;
- 33bM. Wan, A. M. van der VanderDoes, X. Tang, L. Lindbom, B. Agerberth, J. Z. Haeggström, J. Leukocyte Biol. 2014, 95, 971–981.
- 34N. Mookherjee, R. E. W. Hancock, Cell. Mol. Life Sci. 2007, 64, 922–933.
- 35Q. Chen, Y. Jin, K. Zhang, H. Li, W. Chen, G. Meng, X. Fang, Innate Immun. 2014, 20, 290–300.
- 36N. Mookherjee, H. L. Wilson, S. Doria, Y. Popowych, R. Falsafi, J. J. Yu, Y. Li, S. Veatch, F. M. Roche, K. L. Brown, F. S. L. Brinkman, F. S. L. K. Hokamp, A. Potter, L. A. Babiuk, P. J. Griebel, R. E. W. Hancock, J. Leukocyte Biol. 2006, 80, 1563–1574.
Citing Literature
This is the
German version
of Angewandte Chemie.
Note for articles published since 1962:
Do not cite this version alone.
Take me to the International Edition version with citable page numbers, DOI, and citation export.
We apologize for the inconvenience.